DK1242119T3 - Kombinationer til behandling af DNA-virale infektioner omfattende et loop-diuretikum og et hjerteglycosid - Google Patents
Kombinationer til behandling af DNA-virale infektioner omfattende et loop-diuretikum og et hjerteglycosidInfo
- Publication number
- DK1242119T3 DK1242119T3 DK00981499T DK00981499T DK1242119T3 DK 1242119 T3 DK1242119 T3 DK 1242119T3 DK 00981499 T DK00981499 T DK 00981499T DK 00981499 T DK00981499 T DK 00981499T DK 1242119 T3 DK1242119 T3 DK 1242119T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- viral infections
- combinations
- cardiac glycoside
- dna viral
- Prior art date
Links
- 208000036142 Viral infection Diseases 0.000 title abstract 2
- 229940097217 cardiac glycoside Drugs 0.000 title abstract 2
- 239000002368 cardiac glycoside Substances 0.000 title abstract 2
- 239000002171 loop diuretic Substances 0.000 title abstract 2
- LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 title abstract 2
- 229930002534 steroid glycoside Natural products 0.000 title abstract 2
- 230000009385 viral infection Effects 0.000 title abstract 2
- 239000011885 synergistic combination Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Eyeglasses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9930811.6A GB9930811D0 (en) | 1999-10-15 | 1999-12-30 | Anti-viral treatment |
| GB0000683A GB0000683D0 (en) | 1999-10-15 | 2000-01-12 | Antiviral treatment |
| GB0023198A GB0023198D0 (en) | 1999-12-30 | 2000-09-21 | Treatment of DNA viral infections |
| PCT/GB2000/004793 WO2001049242A2 (en) | 1999-12-30 | 2000-12-13 | Combinations for the treatment of dna viral infections comprising a loop diuretic cardiac glycoside |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1242119T3 true DK1242119T3 (da) | 2004-08-02 |
Family
ID=27255465
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00981499T DK1242119T3 (da) | 1999-12-30 | 2000-12-13 | Kombinationer til behandling af DNA-virale infektioner omfattende et loop-diuretikum og et hjerteglycosid |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6894030B2 (da) |
| EP (1) | EP1242119B1 (da) |
| JP (1) | JP2003519163A (da) |
| KR (1) | KR100843790B1 (da) |
| CN (1) | CN1414863A (da) |
| AT (1) | ATE261737T1 (da) |
| AU (1) | AU777339B2 (da) |
| BR (1) | BR0016831A (da) |
| CA (1) | CA2395016C (da) |
| DE (1) | DE60009146T2 (da) |
| DK (1) | DK1242119T3 (da) |
| ES (1) | ES2218254T3 (da) |
| IL (1) | IL150286A0 (da) |
| MX (1) | MXPA02006489A (da) |
| PT (1) | PT1242119E (da) |
| TR (1) | TR200401363T4 (da) |
| WO (1) | WO2001049242A2 (da) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7214711B2 (en) * | 1998-12-23 | 2007-05-08 | Neurotherapeutics Pharma Llc | Method of treating migraine headache without aura |
| US8008283B2 (en) * | 1998-12-23 | 2011-08-30 | Neurotherapeutics Pharma, Inc. | Methods and compositions for the treatment of neuropsychiatric disorders |
| US8722668B2 (en) * | 1998-12-23 | 2014-05-13 | Daryl W. Hochman | Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders |
| GB2367242B (en) * | 2000-09-21 | 2004-07-28 | Henderson Morley Res & Dev Ltd | Antiviral treatment |
| GB2376628B (en) * | 2001-06-19 | 2005-06-08 | Henderson Morley Res & Dev Ltd | Treatment of DNA viral infections in cats |
| DE60139134D1 (de) * | 2000-09-21 | 2009-08-13 | Henderson Morley Res & Dev Ltd | Diuretikum oder sulfonylharnstoff zur benutzung in antiviraler behandlung |
| US7534768B2 (en) * | 2000-12-13 | 2009-05-19 | Henderson Morely Research And Development Ltd. | Treatment of DNA viral infections |
| WO2003099011A1 (en) * | 2002-05-28 | 2003-12-04 | Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders |
| DE10223932A1 (de) * | 2002-05-29 | 2003-12-18 | Rudolf Wank | Verwendung von Diuretika zur Behandlung von Schwellungen |
| EP3257509A1 (en) | 2003-02-12 | 2017-12-20 | Georgetown University | Use of artemisinin and related compounds for treating anorectal squamous cell cancer induced by human papilloma virus |
| GB2413282B (en) * | 2004-04-23 | 2009-01-14 | Henderson Morley Plc | DNA Viral Infections |
| GB0517840D0 (en) * | 2005-09-02 | 2005-10-12 | Henderson Morley Plc | Topical anti viral formulations |
| GB0517838D0 (en) * | 2005-09-02 | 2005-10-12 | Henderson Morley Plc | Transdermal active principle delivery means |
| WO2007047447A2 (en) * | 2005-10-17 | 2007-04-26 | Neurotherapeutics Pharma, Inc. | Diuretic-like compound analogs useful for regulation of central nervous system disorders |
| GB0616451D0 (en) * | 2006-08-18 | 2006-09-27 | Henderson Morley Plc | Dna viral infections |
| CN106562982A (zh) * | 2016-09-27 | 2017-04-19 | 苏州系统医学研究所 | 强心苷类化合物在抗埃博拉病毒感染中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03240732A (ja) * | 1990-02-14 | 1991-10-28 | Yasuo Tanaka | 抗ウイルス剤 |
| US7071230B2 (en) * | 1997-10-02 | 2006-07-04 | Board Of Trustees Of Southern Illinois University | Therapeutic use of D-methionine to reduce the toxicity of noise |
| AU5492899A (en) * | 1998-08-24 | 2000-03-14 | Hadasit Medical Research Services & Development Company Ltd | The use of loop diuretics for hiv infection |
| AU1873101A (en) * | 1999-12-30 | 2001-07-16 | Henderson Morley Research And Development Limited | Synergistic treatment of dna viral infections |
-
2000
- 2000-12-13 WO PCT/GB2000/004793 patent/WO2001049242A2/en not_active Ceased
- 2000-12-13 TR TR2004/01363T patent/TR200401363T4/xx unknown
- 2000-12-13 CA CA002395016A patent/CA2395016C/en not_active Expired - Fee Related
- 2000-12-13 EP EP00981499A patent/EP1242119B1/en not_active Expired - Lifetime
- 2000-12-13 KR KR1020027008450A patent/KR100843790B1/ko not_active Expired - Fee Related
- 2000-12-13 PT PT00981499T patent/PT1242119E/pt unknown
- 2000-12-13 MX MXPA02006489A patent/MXPA02006489A/es active IP Right Grant
- 2000-12-13 US US10/168,945 patent/US6894030B2/en not_active Expired - Lifetime
- 2000-12-13 AU AU18734/01A patent/AU777339B2/en not_active Ceased
- 2000-12-13 DE DE60009146T patent/DE60009146T2/de not_active Expired - Lifetime
- 2000-12-13 BR BR0016831-9A patent/BR0016831A/pt not_active Application Discontinuation
- 2000-12-13 IL IL15028600A patent/IL150286A0/xx not_active IP Right Cessation
- 2000-12-13 DK DK00981499T patent/DK1242119T3/da active
- 2000-12-13 ES ES00981499T patent/ES2218254T3/es not_active Expired - Lifetime
- 2000-12-13 CN CN00818063A patent/CN1414863A/zh active Pending
- 2000-12-13 JP JP2001549611A patent/JP2003519163A/ja active Pending
- 2000-12-13 AT AT00981499T patent/ATE261737T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| AU777339B2 (en) | 2004-10-14 |
| JP2003519163A (ja) | 2003-06-17 |
| ES2218254T3 (es) | 2004-11-16 |
| US6894030B2 (en) | 2005-05-17 |
| CA2395016C (en) | 2009-04-14 |
| KR20030005162A (ko) | 2003-01-17 |
| WO2001049242A2 (en) | 2001-07-12 |
| AU1873401A (en) | 2001-07-16 |
| US20030050253A1 (en) | 2003-03-13 |
| IL150286A0 (en) | 2002-12-01 |
| WO2001049242A3 (en) | 2002-07-11 |
| ATE261737T1 (de) | 2004-04-15 |
| KR100843790B1 (ko) | 2008-07-03 |
| EP1242119A2 (en) | 2002-09-25 |
| EP1242119B1 (en) | 2004-03-17 |
| MXPA02006489A (es) | 2003-09-22 |
| DE60009146D1 (de) | 2004-04-22 |
| BR0016831A (pt) | 2002-09-10 |
| PT1242119E (pt) | 2004-08-31 |
| TR200401363T4 (tr) | 2004-08-23 |
| DE60009146T2 (de) | 2005-02-17 |
| CA2395016A1 (en) | 2001-07-12 |
| CN1414863A (zh) | 2003-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1242119T3 (da) | Kombinationer til behandling af DNA-virale infektioner omfattende et loop-diuretikum og et hjerteglycosid | |
| NO20005839D0 (no) | Preparater for behandling av HIV og andre virale infeksjoner | |
| ATE342097T1 (de) | Elektroaktive pore | |
| FI891716A7 (fi) | HIV-proteaasi-inhibiittoreita, jotka ovat käyttökelpoisia AIDS'in hoidossa | |
| FI981591L (fi) | AIDS:n hoidossa käyttökelpoisia HIV-proteaasi-inhibiittoreita | |
| NO954635D0 (no) | Ribozymgenterapi for HIV infeksjoner og AIDS | |
| NO20021449L (no) | Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og deres anvendelse | |
| FI955315L (fi) | HIV:n proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDS'n hoitoon | |
| DK1021410T3 (da) | Prostaglandinagonister og deres anvendelse til behandling af knogletilstande | |
| FI923158A7 (fi) | HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoidossa | |
| FI953717L (fi) | 4-Hydroksibentsopyran-2-oneja ja 4-hydroksisykloalkyyli(b)pyran-2-oneja, joita voidaan käyttää retrovirusinfektioiden hoitamiseen | |
| NO910816L (no) | Forbedrede betongblandinger og deres anvendelse. | |
| NO912960D0 (no) | Polylaktider, deres fremstilling og anvendelse. | |
| DK1212317T3 (da) | Indolderivater og anvendelse deraf til behandling af osteoporose blandt andre anvendelser | |
| NO943682D0 (no) | Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse | |
| NO20014270D0 (no) | Pyridopyranoazepinderivater, deres fremstilling og terapeutisk anvendelse | |
| NO960775D0 (no) | Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner | |
| DK0983271T3 (da) | Carbocyklisk nucleosidhemisulfat og anvendelsen deraf i behandlingen af virusinfektioner | |
| DK147088D0 (da) | Middel til behandling af virale infektioner i mennesker | |
| NO923507D0 (no) | Heteropolycykliske, biocide forbindelser og deres anvendelse i medisinen | |
| NO991581D0 (no) | N-(benzotiazol-2-yl)piperidin-1-etanaminderivater, deres fremstilling og anvendelse i terapeutiske midler | |
| DK35588A (da) | Hoejniveau-ekspression i e. coli af oploeseligt, modent humant interleukin-1beta og derivater med aendret biologisk virkning | |
| AU1873101A (en) | Synergistic treatment of dna viral infections | |
| TR200002939T2 (tr) | Paroksetin maleat | |
| NO992436D0 (no) | N(imidazolylbutyl)benzensulfonamidderivater, deres fremstilling og terapeutiske anvendelse |